Company / Capital Expenditures
Perrigo Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$93.4M
FY2025
5-year range
$93.4M / $170.4M
FY2021-FY2025
Trend
-21.0%
vs FY2024
Sector context
#22 of 194
Health Care
What the data says
Perrigo's capital expenditures of $93M is higher than 89% of companies in the Health Care sector (FY2025). Capital Expenditures has fluctuated over the past 10 years, ranging from $89M in FY2019 to $170M in FY2022.
Based on SEC 10-K filings.
$93M in FY2025 with a 5-year CAGR of -11.3%. Top quartile in the Health Care sector.
Declined from $102M to $93M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -18.2%
- 5-Year CAGR
- -11.3%
- 10-Year CAGR
- -
Sector benchmark
-20.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -11.3%, indicating a declining trend.
- In FY2025, capital expenditures decreased 21.0% year-over-year.
- Ranks #22 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $93.4M | -21.0% |
| FY2024 | $118.3M | +16.3% |
| FY2023 | $101.7M | -40.3% |
| FY2022 | $170.4M | +23.7% |
| FY2021 | $137.7M | -19.2% |
| FY2020 | $170.4M | +92.3% |
| FY2019 | $88.6M | -16.6% |
| FY2018 | $106.2M | +19.9% |
| FY2017 | $88.6M | -16.6% |
| FY2016 | $106.2M | -22.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026